BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2158.56 only $755.50

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,021.63
      0.57%
      US Tech 100
      20,367.60
      0.51%
      Dow Jones
      44,860.31
      0.28%
      Brent Oil
      72.425
      -0.03%
      Bitcoin
      92,676.38
      0.77%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Lacroix Sa (0F1U) Quote

      Lacroix Sa

      Lacroix Sa (0F1U)

      LSE
      33.20
      0.00
      (0.00%)
      Closed November 27 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      33.20
      Bid
      0.00
      Ask
      0.00
      Volume
      0.00
      0.00 Day's Range 0.00
      33.20 52 Week Range 33.20
      Market Cap
      160.323M
      Previous Close
      33.20
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      0.00
      Shares Outstanding
      4,829,000
      Dividend Yield
      -
      PE Ratio
      12.05
      Earnings Per Share (EPS)
      0.88
      Revenue
      764.76M
      Net Profit
      4.27M

      About Lacroix Sa

      Sector
      Indl, Coml Machy, Equip, Nec
      Industry
      Elec Meas & Test Instruments
      Website
      www.lacroix-group.com
      Headquarters
      Saint-herblain, Loire-atlantique, Fra
      Founded
      1993
      Lacroix Sa is listed in the Indl, Coml Machy, Equip sector of the London Stock Exchange with ticker 0F1U. The last closing price for Lacroix was 33.20 €. Over the last year, Lacroix shares have traded in a share price range of 33.20 € to 33.20 €.

      Lacroix currently has 4,829,000 shares outstanding. The market capitalization of Lacroix is 160.32 € million. Lacroix has a price to earnings ratio (PE ratio) of 12.05.

      Ask ADVFN Intelligence (AI)

      0F1U Latest News

      More News

      FeaturedCannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

      16 hours ago

      FeaturedBioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL

      17 hours ago

      LACROIX : In a persistently buoyant market, the activity Environment of LACROIX successfully revitalizes its offer in all segments.

      LACROIX : In a persistently buoyant market, the activity Environment of LACROIX successfully revitalizes its offer in all segments. In a persistently buoyant market, the activity Environment of...

      November 25 2024
      UK Regulatory

      LACROIX : Sur un marché durablement porteur, l’activité Environment de LACROIX renouvelle avec succès son offre sur tous ses segments.

      LACROIX : Sur un marché durablement porteur, l’activité Environment de LACROIX renouvelle avec succès son offre sur tous ses segments. Sur un marché durablement porteur, l’activité Environment de...

      November 25 2024
      UK Regulatory

      LACROIX : Consolidated revenue of €494,2 million for the first 9 months of FY 2024, down 6.3% on a like-for-like basis.

      LACROIX : Consolidated revenue of €494,2 million for the first 9 months of FY 2024, down 6.3% on a like-for-like basis. Consolidated revenue of €494,2 million for the first 9 months of FY 2024...

      November 07 2024
      UK Regulatory

      LACROIX : Le chiffre d’affaires consolidé ressort à 494,2 M€ sur les 9 premiers mois de l’exercice 2024, en repli de 6,3% à périmètre constant.

      LACROIX : Le chiffre d’affaires consolidé ressort à 494,2 M€ sur les 9 premiers mois de l’exercice 2024, en repli de 6,3% à périmètre constant. Le chiffre d’affaires consolidé ressort à 494,2 M€...

      November 07 2024
      UK Regulatory

      LACROIX : First-half 2024: €350.3m revenue, down 4.9% on a like-for-like basis. Increase in current operating profitability, excl. North America.

      LACROIX : First-half 2024: €350.3m revenue, down 4.9% on a like-for-like basis. Increase in current operating profitability, excl. North America. 30/09/2024 First-half 2024: €350.3m revenue, down...

      September 30 2024
      UK Regulatory

      LACROIX : Premier semestre 2024 : Chiffre d’affaires 2024 de 350,3 M€, en repli de 4,9% à périmètre constant. Progression de la rentabilité opérationnelle courante, hors Amérique du Nord.

      LACROIX : Premier semestre 2024 : Chiffre d’affaires 2024 de 350,3 M€, en repli de 4,9% à périmètre constant. Progression de la rentabilité opérationnelle courante, hors Amérique du Nord...

      September 30 2024
      UK Regulatory

      LACROIX : After two years in operation, LACROIX’s Symbiose plant in Beaupréau-en-Mauges shows solid growth.

      LACROIX : After two years in operation, LACROIX’s Symbiose plant in Beaupréau-en-Mauges shows solid growth. After two years in operation, LACROIX’s Symbiose plant in Beaupréau-en-Mauges shows...

      September 16 2024
      UK Regulatory

      LACROIX : Deux ans après son ouverture, l’usine Symbiose de LACROIX à Beaupréau-en-Mauges affiche une croissance solide.

      LACROIX : Deux ans après son ouverture, l’usine Symbiose de LACROIX à Beaupréau-en-Mauges affiche une croissance solide. Deux ans après son ouverture, l’usine Symbiose de LACROIX à...

      September 16 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10033.233.233.200DE
      40033.233.233.2133.2DE
      120033.233.233.2033.2DE
      260033.233.233.2033.2DE
      520033.233.233.2033.2DE
      1560033.233.233.22033.2DE
      2600033.233.233.21333.2DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ORCPOracle Power Plc
      0.0305p
      (158.47%)
      		6.24B
      STKStreaksai Plc
      0.35p
      (59.09%)
      		8.58M
      QEDQuadrise Plc
      3.62p
      (57.39%)
      		94.06M
      ENWEnwell Energy Plc
      23.00p
      (46.03%)
      		160.81k
      WEBWebis Holdings Plc
      0.125p
      (38.89%)
      		9.14M
      INXI-nexus Global Plc
      1.50p
      (-52.38%)
      		7.25M
      SFRSeverfield Plc
      55.60p
      (-36.24%)
      		9.71M
      LENDSancus Lending Group Limited
      0.30p
      (-33.33%)
      		1.23M
      TRYBTribe Technology Plc
      2.45p
      (-20.97%)
      		80k
      GWMOGreat Western Mining Corporation Plc
      0.0175p
      (-20.45%)
      		169.92M
      ORCPOracle Power Plc
      0.0305p
      (158.47%)
      		6.24B
      NTVONativo Resources Plc
      0.0025p
      (0.00%)
      		3.46B
      TRPTower Resources Plc
      0.0275p
      (0.00%)
      		526.88M
      CPXCap-xx Limited
      0.145p
      (-13.43%)
      		499.92M
      MSMNMosman Oil And Gas Limited
      0.038p
      (-1.30%)
      		329.43M

      Discussion

      View Full Feed
      jondoeuk jondoeuk 3 minutes ago
      A post on LinkedIn (by Alex Shih-Min Huang who is VP, Head of Cell Therapy at BGNE): 'Though our very first experiment was initiated only 2.5 years ago amidst ongoing laboratory construction and pandemic, fast forward to this day, we have already 1) generated a proprietary, well-characterized GMP gr
      BGNE
      gfp927z gfp927z 3 minutes ago
      Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000


      Barron's

      by Paul R. La Monica

      Nov 22, 2024


      https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2
      ACXP
      dinogreeves dinogreeves 4 minutes ago
      Analyst are going to scratch their heads tomorrow if there is no press release based on all the notes fully paid off, upwards of 2 billion dollars, if the numbers were cooked and there was going to be fraud charges against the company, they would have taken the money and ran, but instead they paid i
      SMCI
      bluebird50 bluebird50 5 minutes ago
      Guess crows don't like coffee.... delete this post and Crows... 

      ;-) so we don't witness a murder... a group of crows... Che Che Che 
      RDAR
      BamaBreeze BamaBreeze 5 minutes ago
      Good on you!! Bless us.
      BLLB
      ducci1 ducci1 5 minutes ago
      Pivot Calcs: SPX Pivot--6012----R1--6033----R2--6045----S1--6000----S2--5980-----SPY Pivot--599----R1--601----R2--602----S1--598----S2--596-----VIX Pivot--14.33 !!LOL!!
      VIX
      imnot6 imnot6 6 minutes ago
      Well, extended duration is their value proposition...
      JohnnyHydrogen JohnnyHydrogen 6 minutes ago
      AI Czar ?

      https://www.axios.com/2024/11/26/trump-ai-czar-role-elon-musk

      ....

      "The office would spur the massive private investment needed to expand the energy supply to keep the U.S. on the cutting edge."
      FCEL
      gfp927z gfp927z 7 minutes ago
      Bigworld, Here's more info relating to Acurx's recent move to buy some Bitcoin (below). So far that boneheaded decision by Luci has cut Acurx's share price nearly in half -


      Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

      gfp927z gfp927z 12 minutes ago
      Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000


      Barron's

      by Paul R. La Monica

      Nov 22, 2024


      https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2
      Mountainman5 Mountainman5 12 minutes ago
      Red Cat & OPT = WinWin!!!!!!!!!!!!!
      OPTT
      BDEZ BDEZ 13 minutes ago
      Thanks georgie..
      XRPUSD
      $GROO $GROO 14 minutes ago
      Never Quit $SANP
      Never Quit $SANP $GROO ht
      GROO SANP
      Oleblue Oleblue 14 minutes ago
      In this solo lecture, Chris Miller, author of the acclaimed book "Chip War", delves into the intricate world of semiconductors, exploring how microchips have become the cornerstone of global power and economic influence. Miller will provide an analysis of the geopolitical ramifications of semiconduc
      NVDA
      JettaR JettaR 16 minutes ago
      No one is "rooting" for the stock to go down.  Eyes wide open. Eyes wide open. It's right on front of everyone. 
      RGLG
      lambchops lambchops 16 minutes ago
      Peeps ought to gobble up some NFTM shares for gobble-gobble day!

      Eat turkey--not lamb-- on Christmas! Yum-yum.

      Happy T-bird day. And remember,"Fun. Fun, fun till your daddy takes the T-bird awayNFTM
      NFTM
      reaper247 reaper247 18 minutes ago
      Always good to hear from ya Drugdoctor.

      I suspect we have a few people lurking around.

      Hope all GVSIers have as safe and happy Thanksgiving.

      GLTA, IMO and FWIW.
      GVSI
      jondoeuk jondoeuk 18 minutes ago
      One for FT819 as well https://www.globenewswire.com/news-release/2024/11/18/2982757/24675/en/Fate-Therapeutics-Presents-6-Month-Follow-up-Data-on-First-Patient-Treated-in-Phase-1-Autoimmunity-Study-with-Fludarabine-free-Conditioning-and-FT819-Off-the-shelf-1XX-CAR-T-cell-P.html
      FATE
      skitahoe skitahoe 19 minutes ago
      NWBO is in a similar situation in the EU. I believe that you'll find that the 150 days doesn't begin with submission. No one is absolutely certain, some believed it started with preliminary validation, which occurred roughly a month after submission. Others believed it began with final validation
      AVXL NWBO
      jjjjjjjj jjjjjjjj 19 minutes ago
      Gummies for dummies -- yummies , LMAO burger flipper
      Reply privately from blusher.

      Keep doing the 2 steps:
      1. SET SELL HIGH our shares.
      2. SET BUY HIGHssssssss with last minute and price limit.

      MJNA is a good company. Best to us longs.
      MJNA
      jondoeuk jondoeuk 19 minutes ago
      The PR https://www.globenewswire.com/news-release/2024/11/18/2982736/24675/en/Fate-Therapeutics-Highlights-FT522-Off-the-shelf-ADR-armed-CAR-NK-Cell-Product-Candidate-at-2024-ACR-Convergence.html
      FATE
      gfp927z gfp927z 21 minutes ago
      Xena, All I said was that a B-12 deficiency might be the cause of your advancing foot numbness. Gadolinium toxicity might have the same effect (?), but logic says to eliminate other obvious possibilities before concluding that it is the gadolinium.

      >> given the level of supplementa
      jondoeuk jondoeuk 21 minutes ago
      They need to pick up the pace of enrolment. If they don't see activity at DL2, I think it could be in trouble.
      FATE
      Plato_ Plato_ 26 minutes ago
      https://investorshub.advfn.com/uimage/uploads/2024/11/27/hcolltrade-error-314217-the-share-quanitty-is-limited.png
      Source: https://www.reddit.com/r/fidelityinvestments/comments/1grxuld/comment/ly9voew

      FYI. Found this on a subreddit regarding Fidelity restrictions on trade size.
      GDVM
      gimmegimmeminemine gimmegimmeminemine 27 minutes ago
      At a bare minimum, I want to see viable proof that they have solved the issue of mass scale production, cost effectively on a quality consistent basis.
      Clear and consice viable proof.

      I would be ecstatic if they are ready or already putting out product on a regular basis, be i
      KBLB

      Your Recent History

      LSE
      0F1U
      Lacroix
      Delayed Upgrade Clock